When LPs Become More Strategic, GPs Need to Become More Useful

As Japanese LPs move from allocation toward capability building, GPs may need to offer more than fund performance: risk language, education, reporting support, and relationship design.

Share
When LPs Become More Strategic, GPs Need to Become More Useful

What happened

Recent moves by Japanese insurers suggest that the private-market relationship between capital owners and asset managers is becoming more strategic. Nippon Life's comprehensive partnership with Blackstone is one visible example. The partnership includes an expected JPY 1.5 trillion allocation over five years to private credit and structured credit strategies, as well as real estate initiatives and broader collaboration around investment capabilities, training, and risk management.

This piece follows my earlier note on why Japan's insurers may be moving from allocation toward capability building: Japan's Insurers Are Moving From Allocation to Capability Building.

Other Japanese financial institutions have also been moving in directions that go beyond simple fund commitments. Dai-ichi Life Holdings announced an investment in Canyon Partners in 2024. Japan Post Insurance, Daiwa Securities Group, Daiwa Asset Management, and Mitsui announced a capital and business alliance in alternative asset management in 2025. These are different transactions, but they point to a similar question: what happens when Japanese LPs want more than exposure?

The usual reading is that Japan is becoming a more important market for alternative assets. That is true. But for GPs, the more important signal may be different. If LPs become more strategic, the competitive bar for GPs also changes.

Why this matters

For many years, the basic fundraising story was relatively simple. A GP had a fund strategy, a track record, a team, and a target allocation from LPs. The LP evaluated the manager and decided whether to commit. Of course, the actual process was always more complex, but the conceptual relationship was still centered on capital allocation.

That model is no longer enough in some parts of the market. Large institutional LPs increasingly need help with more than performance. They need risk explanation, reporting infrastructure, internal education, product design, co-investment thinking, and the ability to connect private-market strategies to their own balance sheet, client base, or business model.

This is especially relevant in Japan. Large insurers and other financial institutions may have scale and long-duration liabilities, but that does not automatically mean they have fully developed private-market operating systems. As alternatives become more important, they need to build internal conviction, governance, and practical knowledge. A GP that only says "we have good returns" may not be speaking to the full problem.

The implication is uncomfortable for domestic GPs. The competition may not only be the domestic manager next door. It may be a global multi-asset platform that can bring private credit, real estate, infrastructure, secondaries, reporting frameworks, training sessions, product ideas, risk language, and institutional credibility as a package.

How I see it

My view is that Japanese domestic GPs need to stop thinking of LP demand as a simple tailwind. More institutional interest in alternatives is positive, but it does not guarantee that domestic managers will capture the capital.

If Japanese LPs are moving from allocation to capability building, then the GP's job changes. The GP is not only selling access to deals or a fund strategy. The GP is helping the LP understand why the strategy matters, how the risk should be explained, how the exposure fits into a broader portfolio, and how the relationship can create knowledge over time.

This does not mean every GP needs to become a global platform. That would be unrealistic and unnecessary. Domestic managers can have advantages that global platforms do not have: local sourcing, sector knowledge, founder relationships, regulatory familiarity, cultural fluency, and a more direct understanding of Japanese business networks.

But those advantages need to be translated into institutional value. A local edge is not enough if the LP cannot explain it internally. A niche strategy is not enough if the risk language is weak. A strong investment team is not enough if the manager cannot help the LP build confidence across investment committee members, risk teams, product teams, and senior management.

This is why I think the next phase of domestic GP competition will be less about "Can you raise a fund?" and more about "Can you become useful to a strategic LP?"

Implications

For domestic GPs, usefulness has several layers. The first is clarity. LPs need to understand what problem the manager solves, why the strategy belongs in a portfolio, and what risks should be expected. This sounds basic, but many managers still communicate mainly through performance, pipeline, and market opportunity. Strategic LPs need a more complete explanation.

The second is institutional support. A GP does not need to run the LP's internal process, but it can make that process easier. That may include investment committee materials, downside cases, liquidity explanations, scenario analysis, co-investment frameworks, and education sessions for teams that are not close to the asset class.

The third is relationship design. If an LP wants to build capability, the relationship cannot be purely transactional. GPs may need to think about knowledge sharing, periodic market updates, access to operating insights, introductions, and a cadence that helps the LP learn over time. This is not charity. It can make the LP more durable, more informed, and easier to work with across future funds.

For global GPs, the opportunity is to enter Japan not only as fundraisers, but as infrastructure partners. The strongest platforms can package capital deployment with reporting, training, product development, and multi-asset solutions. That is powerful. But it also creates a responsibility: if the partnership is framed as strategic, the GP needs to deliver more than a capital call schedule and quarterly reports.

For LPs, the implication is that manager selection should include a question that is often underweighted: will this GP make us better? Not only in return terms, but in institutional capability. Does the manager help the LP understand the market more clearly? Does it improve internal judgment? Does it create access, discipline, and learning that can compound?

Open question

The question I would watch is whether Japan's domestic GPs can define a value proposition that global multi-asset platforms cannot easily copy.

If they compete only on fund performance, many will struggle against larger firms with broader resources. If they combine local edge with institutional usefulness, they may have a stronger path. The next phase of Japan's private-market ecosystem may depend not only on how much capital LPs allocate, but on which GPs can help those LPs become more capable investors.

References